Home › SEC Filings
SEC Filing Analysis
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| GBC | 424B4 | neutral | 5/10 | Georgia Banking Company, Inc. filed a final prospectus (424B4) for the resale of up to 7,074,016 shares of common stock | Oct 29, 2026 |
| CRH | 8-K | bearish | 6/10 | CRH reported Q3 2026 revenue of $11.4B (+3% YoY) and GAAP diluted EPS of $1.86, below the consensus estimate of $2.03. N | Oct 29, 2026 |
| VRAX | 6-K | neutral | 3/10 | Virax Biolabs announced non-exclusive distribution agreements with three Chinese distributors for its ImmuneSelect resea | Oct 29, 2026 |
| INMB | 8-K | bearish | 6/10 | Inmune Bio entered into a securities purchase agreement for a registered direct offering of 3,000,000 shares at $1.50 pe | Oct 29, 2026 |
| DQ | 6-K | bearish | 5/10 | Daqo New Energy reported Q3 2026 revenue of $194.2M, well above the $65.0M consensus, and a GAAP net loss of $52.9M ($0. | Oct 29, 2026 |
| CART | 8-K | mixed | 9/10 | The release was overshadowed by the simultaneous announcement of a definitive agreement to be acquired by DoorDash for ~ | Oct 29, 2026 |
| MNRO | 8-K | bearish | 5/10 | Monro reported Q2 fiscal 2027 results with sales down 1.8% to $283.6M and a net loss of $1.6M versus net income of $5.7M | Oct 29, 2026 |
| CDLR | SC TO-T/A | mixed | 7/10 | Cadeler plc (NewCo) filed Amendment No. 2 to its Schedule TO, reporting that as of the October 28, 2026 expiration, 355, | Oct 29, 2026 |
| ATI | 8-K | bullish | 6/10 | ATI reported Q3 2026 results with sales of $1.42B (up 26% YoY) and GAAP EPS of $1.37 (up 76% YoY), exceeding the high en | Oct 29, 2026 |
| HLN | 6-K | neutral | 3/10 | Haleon announced a GBP 500 million share buyback programme, to be executed by Citi on the London Stock Exchange, CBOE Eu | Oct 29, 2026 |
| RXO | 8-K | bullish | 6/10 | RXO reported Q3 2026 adjusted EPS of $0.09, beating the $0.07 consensus, and revenue of $1.87B, above the $1.82B consens | Oct 29, 2026 |
| DTM | 8-K | bullish | 6/10 | DT Midstream reported Q3 2026 net income of $118M ($1.16 per diluted share) and Adjusted EBITDA of $301M, with year-to-d | Oct 29, 2026 |
| PHIN | 8-K | bullish | 6/10 | PHINIA reported Q3 2026 net sales of $912M (flat YoY excluding FX) and adjusted EPS of $1.83, beating the $1.68 consensu | Oct 29, 2026 |
| CQP | 8-K | neutral | 5/10 | Cheniere Energy Partners reported Q3 2026 revenue of $2.574B (up 7% YoY) and GAAP net income of $0.639B (up 26% YoY), wi | Oct 29, 2026 |
| CDLR | 6-K | neutral | 5/10 | Cadeler A/S announced preliminary results of its share exchange offer by Cadeler plc, with a 92.02% acceptance rate, in | Oct 29, 2026 |
| NUAI | PRESS-RELEASE | bearish | 5/10 | New Era Energy & Digital announced a PIPE raising approximately $64 million through the issuance of 23,272,727 shares at | Oct 29, 2026 |
| VANI | 8-K | neutral | 2/10 | Vivani Medical filed an 8-K under Item 7.01 to disclose a slide presentation dated October 29, 2026, which provides an u | Oct 29, 2026 |
| LAUR | PRESS-RELEASE | bullish | 6/10 | Laureate Education reported Q3 2026 revenue of $485.1M (+21% YoY reported, +14% constant currency) and GAAP diluted EPS | Oct 29, 2026 |
| LNG | 8-K | bullish | 6/10 | Cheniere Energy reported Q3 2026 revenue of $6.17B (up 39% YoY) and GAAP net income of $1.17B (up 12% YoY), beating cons | Oct 29, 2026 |
| LVWR | 8-K | bearish | 6/10 | LiveWire reported Q3 2026 revenue of $7.9M (+38% YoY) and a net loss of $18.6M, but the headline event is a going concer | Oct 29, 2026 |
| BXMT | 8-K | bearish | 6/10 | BXMT reported Q3 2026 Distributable EPS prior to realized gains and losses of $0.42, below the $0.48 in Q2 2026 and the | Oct 29, 2026 |
| LXEO | S-3 | bearish | 5/10 | Lexeo Therapeutics filed a new universal shelf registration statement on Form S-3, registering up to $300 million in sec | Oct 29, 2026 |
| AGCO | PRESS-RELEASE | bearish | 6/10 | AGCO reported Q3 2026 adjusted EPS of $1.05, beating the $0.86 consensus by 22.1%, but net sales of $2.26B fell short of | Oct 29, 2026 |
| DRS | PRESS-RELEASE | bullish | 6/10 | Leonardo DRS reported Q3 2026 revenue of $1.066B (up 11% YoY) and adjusted diluted EPS of $0.46 (up 59% YoY), both above | Oct 29, 2026 |
| DTM | PRESS-RELEASE | bullish | 6/10 | DT Midstream reported Q3 2026 Operating Earnings of $1.16 per diluted share, beating the $1.13 consensus by 2.7%. The co | Oct 29, 2026 |
| DAVI | PRESS-RELEASE | neutral | 5/10 | Davion Healthcare Plc announces a $13.5M acquisition of Healthcare Stat Homecare Inc. (HSH), a profitable home healthcar | Oct 29, 2026 |
| INMB | 424B5 | bearish | 5/10 | Inmune Bio is offering 3,000,000 shares of common stock at $1.50 per share in a firm-commitment priced equity offering, | Oct 29, 2026 |
| BCBP | PRESS-RELEASE | bearish | 6/10 | BCB Bancorp reported a net loss of $132.5 million for Q3 2026, driven by a $115.0 million provision for credit losses an | Oct 29, 2026 |
| FCN | PRESS-RELEASE | mixed | 6/10 | FTI Consulting reported Q3 2026 revenue of $1.013B, up 6% YoY and above the $1.01B consensus, but GAAP EPS of $2.35 miss | Oct 29, 2026 |
| ICE | 8-K | bullish | 6/10 | ICE reported record Q3 2026 results with net revenues of $2.8 billion (+15% YoY) and adjusted diluted EPS of $2.02 (+18% | Oct 29, 2026 |